Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002044275 | SCV002109963 | uncertain significance | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2022-08-09 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1348358). This variant has not been reported in the literature in individuals affected with SYNE1-related conditions. This variant is present in population databases (rs531503159, gnomAD 0.008%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 3499 of the SYNE1 protein (p.Arg3499Cys). |
Athena Diagnostics | RCV002473308 | SCV002771408 | uncertain significance | not provided | 2022-01-12 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV002473308 | SCV004237936 | uncertain significance | not provided | 2023-06-12 | criteria provided, single submitter | clinical testing |